Financial reports
ARS
2023 FY
Annual report to shareholders
10 Apr 24
10-K
2023 FY
Annual report
14 Feb 24
10-Q
2023 Q3
Quarterly report
31 Oct 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
27 Apr 23
ARS
2022 FY
Annual report to shareholders
30 Mar 23
10-K
2022 FY
Annual report
9 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
27 Apr 22
Current reports
8-K
Amgen Reports Fourth Quarter and Full Year 2023 Financial Results
6 Feb 24
8-K
Amgen Announces Executive Appointments to Accelerate Innovation
14 Dec 23
8-K
Amgen Reports Third Quarter Financial Results
31 Oct 23
8-K
Amgen Completes Acquisition of Horizon Therapeutics PLC
6 Oct 23
8-K
Other Events
5 Oct 23
8-K
Other Events
12 Sep 23
8-K
Other Events
5 Sep 23
8-K
Regulation FD Disclosure
1 Sep 23
8-K
Departure of Directors or Certain Officers
3 Aug 23
8-K
Amgen Reports Second Quarter Financial Results
3 Aug 23
Registration and prospectus
S-8
Registration of securities for employees
6 Oct 23
424B2
Prospectus for primary offering
16 Feb 23
FWP
Free writing prospectus
15 Feb 23
424B3
Prospectus supplement
14 Feb 23
S-3ASR
Automatic shelf registration
9 Feb 23
424B2
Prospectus for primary offering
16 Aug 22
FWP
Free writing prospectus
15 Aug 22
424B3
Prospectus supplement
15 Aug 22
424B2
Prospectus for primary offering
18 Feb 22
FWP
Free writing prospectus
17 Feb 22
Proxies
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEFA14A
Additional proxy soliciting materials
17 Apr 24
DEF 14A
Definitive proxy
17 Apr 24
DEFA14A
Additional proxy soliciting materials
3 May 23
DEFA14A
Additional proxy soliciting materials
25 Apr 23
DEFA14A
Additional proxy soliciting materials
14 Apr 23
DEFA14A
Additional proxy soliciting materials
6 Apr 23
DEF 14A
Definitive proxy
6 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 22
DEFA14A
Additional proxy soliciting materials
22 Apr 22
Other
EFFECT
Notice of effectiveness
16 Apr 21
CORRESP
Correspondence with SEC
13 Apr 21
UPLOAD
Letter from SEC
18 Feb 21
CORRESP
Correspondence with SEC
9 Feb 21
CERT
Certification of approval for exchange listing
28 Dec 20
CT ORDER
Confidential treatment order
24 Oct 19
CT ORDER
Confidential treatment order
3 Jun 19
CT ORDER
Confidential treatment order
30 May 18
CT ORDER
Confidential treatment order
17 May 18
CT ORDER
Confidential treatment order
4 Dec 17